Search Videos and More
Researcher is awarded grant from BrightFocus Foundation’s National Glaucoma Research Program
UCI researcher receives BrightFocus funding to explore how eye pressure and aging impact vision loss.Four UCI Health Hospitals earn top honor
Four hospitals recognized by the American Heart Association for excellence in stroke, heart failure, and diabetes care.UCI Health grows their structural heart program
Our interventional cardiologists and heart surgeons work together to treat conditions without open-heart surgery.Getting help for thyroid eye disease
Jeremiah Tao, MD, left, and Lilangi Ediriwickrema, MD work closely with a team of specialists to treat thyroid eye disease.Deepti Pandita, MD honored with HIMSS Changemaker Award
Deepti Pandita, MD, has been honored with a Healthcare Information and Management Systems Society (HIMSS) Changemaker Award.Oncologists discuss first day of American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
Obesity-uterine cancer link a ‘public health’ emergencyUCI Health launches first U.S. trial of nerve-blocking device for drug-resistant hypertension
A new clinical trial at UCI Health tests a novel device that could help millions with uncontrolled high blood pressure reduce or eliminate medications.UCI Health hosts Second Annual World UBE Society America Meeting
Spine experts from around the world gathered together for the Second Annual World UBE Society America Meeting.UCI School of Medicine receives prestigious grant from Research to Prevent Blindness
Funding will support eye research conducted by the Department of Ophthalmology.Recent gift allows for expansion of cardiovascular resources
The goal and the mission for the Mary and Steve Wen Cardiovascular Division is to provide the highest quality of care for our patients in Orange County.Yarah Haidar, MD: Oropharyngeal cancer
"With the rise in HPV-associated oropharyngeal cancers, we do see patients in their 30's and 40's with oropharyngeal cancers," says UCI Health head and neck surgeon Yarah Haidar, MD.Reimagining precision oncology: Richard Van Etten, MD, PhD shares ASCO 2025 insights
Richard Van Etten, MD, PhD, director of the UCI Health Chao Family Comprehensive Cancer Center, highlights emerging insights in precision oncology at ASCO 2025 — including the growing role of epigenetics, transcriptomics, and proteomics in tailoring cancer care.